SCHEMBL7188124

SCHEMBL7188124

CCCCCOc1ccc(CC)cc1CCC(=O)c1cccc(OCCCCC)c1OCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 2/20 0.47
MAPT P10636 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 3/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NR1I2 O75469 1/20 0.43
CHRM2 P08172 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADRA2A P08913 1/20 0.43
OPRK1 P41145 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
THRB P10828 2/20 0.41
MAPK1 P28482 2/20 0.41
APAF1 O14727 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194170 0.99 LTB4R (0.49) LTB4RMAPTMEN1KMT2AHTT
SCHEMBL7197274 0.97 LTB4R (0.43) LTB4RMAPTMEN1KMT2AHTT
SCHEMBL7195763 0.93 LTB4R (0.40) LTB4RMEN1KMT2ASMN1; SMN2CNR1
SCHEMBL7194132 0.90 MEN1 (0.51) LTB4RMAPTMEN1KMT2AHTT
SCHEMBL7197384 0.89 LMNA (0.53) LTB4RMAPTMEN1KMT2AHTT
SCHEMBL7189170 0.88 LTB4R (0.48) LTB4RMAPTMEN1KMT2ALMNA
SCHEMBL7196635 0.87 LTB4R (0.50) LTB4RMAPTMEN1KMT2ALMNA
SCHEMBL7192422 0.86 ABCB1 (0.40) MAPTKMT2ALMNAL3MBTL1NPSR1
SCHEMBL7193867 0.86 LTB4R (0.51) LTB4RMAPTMEN1KMT2AHTT
SCHEMBL7198626 0.86 LMNA (0.46) LTB4RMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 LTB4R 506/4885MAPT 3817/4885MEN1 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.